Qiagen (QGEN) Net Income towards Common Stockholders Growth (3y) (2012 - 2025)
Qiagen (QGEN) Net Income towards Common Stockholders Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -7.69% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 15.47% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -6.41% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 14.70% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 2.87% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 16.51% |
| 10 | Qiagen | 9.49 Bn | 8.72 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62.34% |
| Jun 30, 2025 | 3.81% |
| Mar 31, 2025 | -13.04% |
| Dec 31, 2024 | -7.18% |
| Jun 30, 2024 | -7.42% |
| Mar 31, 2024 | -12.27% |
| Dec 31, 2023 | 30.90% |
| Sep 30, 2023 | -16.98% |
| Mar 31, 2023 | 28.77% |
| Dec 31, 2022 | -18.19% |
| Jun 30, 2022 | 38.18% |
| Mar 31, 2022 | 84.04% |
| Dec 31, 2021 | 25.33% |
| Jun 30, 2021 | 61.47% |
| Mar 31, 2021 | 68.32% |
| Dec 31, 2020 | -10.36% |
| Sep 30, 2020 | 41.03% |
| Mar 31, 2020 | 31.16% |
| Dec 31, 2019 | 2.33% |
| Mar 31, 2019 | 23.52% |